Sensei Biotherapeutics (NASDAQ:SNSE) Announces Quarterly Earnings Results, Meets Estimates

Sensei Biotherapeutics (NASDAQ:SNSE) announced its earnings results on Friday. The company reported ($0.27) EPS for the quarter, hitting the consensus estimate of ($0.27), Zacks reports.

Sensei Biotherapeutics Stock Up 18.0 %

SNSE traded up $0.08 during trading on Friday, hitting $0.51. The company’s stock had a trading volume of 145,672,542 shares, compared to its average volume of 898,433. The firm has a market capitalization of $12.78 million, a P/E ratio of -0.43 and a beta of 0.16. Sensei Biotherapeutics has a twelve month low of $0.38 and a twelve month high of $1.94. The stock’s fifty day moving average price is $0.47 and its 200-day moving average price is $0.49.

Analyst Upgrades and Downgrades

A number of research firms recently commented on SNSE. Oppenheimer upped their target price on Sensei Biotherapeutics from $3.50 to $4.00 and gave the company an “outperform” rating in a report on Friday. HC Wainwright reaffirmed a “buy” rating and issued a $4.00 price objective on shares of Sensei Biotherapeutics in a research note on Friday.

Sensei Biotherapeutics Company Profile

Sensei Biotherapeutics, Inc, an immuno-oncology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment.